Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.

Burton S, Spicer LM, Charles TP, Gangadhara S, Reddy PBJ, Styles TM, Velu V, Kasturi SP, Legere T, Hunter E, Pulendran B, Amara R, Hraber P, Derdeyn CA.

J Virol. 2019 Mar 21;93(7). pii: e01846-18. doi: 10.1128/JVI.01846-18. Print 2019 Apr 1.

PMID:
30651354
2.

Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses.

Chea LS, Wyatt LS, Gangadhara S, Moss B, Amara RR.

J Virol. 2019 Feb 19;93(5). pii: e01648-18. doi: 10.1128/JVI.01648-18. Print 2019 Mar 1.

PMID:
30541829
3.

Intragastric Administration of Lactobacillus plantarum and 2,2'-Dithiodipyridine-Inactivated Simian Immunodeficiency Virus (SIV) Does Not Protect Indian Rhesus Macaques from Intrarectal SIV Challenge or Reduce Virus Replication after Transmission.

Carnathan DG, Mackel JJ, Sweat SL, Enemuo CA, Gebru EH, Dhadvai P, Gangadhara S, Hicks S, Vanderford TH, Amara RR, Esparza J, Lu W, Andrieu JM, Silvestri G.

J Virol. 2018 Apr 27;92(10). pii: e02030-17. doi: 10.1128/JVI.02030-17. Print 2018 May 15.

4.

Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.

Gangadhara S, Kwon YM, Jeeva S, Quan FS, Wang B, Moss B, Compans RW, Amara RR, Jabbar MA, Kang SM.

Vaccines (Basel). 2017 Dec 19;5(4). pii: E52. doi: 10.3390/vaccines5040052.

5.

Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue.

Snyder M, Gangadhara S, Brohl AS, Ludlow S, Nanjappa S.

Cancer Control. 2017 Oct-Dec;24(5):1073274817729070. doi: 10.1177/1073274817729070.

6.

Rhabdomyolysis and Autoimmune Variant Stiff-Person Syndrome.

Gangadhara S, Gangadhara S, Gandhy C, Robertson D.

Clin Pract. 2016 Nov 30;6(4):885. doi: 10.4081/cp.2016.885. eCollection 2016 Oct 24.

7.

High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques.

Kannanganat S, Wyatt LS, Gangadhara S, Chamcha V, Chea LS, Kozlowski PA, LaBranche CC, Chennareddi L, Lawson B, Reddy PB, Styles TM, Vanderford TH, Montefiori DC, Moss B, Robinson HL, Amara RR.

J Immunol. 2016 Nov 1;197(9):3586-3596. Epub 2016 Sep 28.

8.

Induction of Th1-Biased T Follicular Helper (Tfh) Cells in Lymphoid Tissues during Chronic Simian Immunodeficiency Virus Infection Defines Functionally Distinct Germinal Center Tfh Cells.

Velu V, Mylvaganam GH, Gangadhara S, Hong JJ, Iyer SS, Gumber S, Ibegbu CC, Villinger F, Amara RR.

J Immunol. 2016 Sep 1;197(5):1832-42. doi: 10.4049/jimmunol.1600143. Epub 2016 Aug 1.

9.

Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.

Iyer SS, Gangadhara S, Victor B, Shen X, Chen X, Nabi R, Kasturi SP, Sabula MJ, Labranche CC, Reddy PB, Tomaras GD, Montefiori DC, Moss B, Spearman P, Pulendran B, Kozlowski PA, Amara RR.

J Virol. 2016 Sep 12;90(19):8842-54. doi: 10.1128/JVI.01163-16. Print 2016 Oct 1.

10.

3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response.

Gangadhara S, Smith C, Barrett-Lee P, Hiscox S.

BMC Cancer. 2016 Jun 1;16:345. doi: 10.1186/s12885-016-2377-z.

11.

The Significance of REM Sleep on Routine EEG.

Gangadhara S, Pizarro-Otero J, Bozorg A, Benbadis S.

Neurodiagn J. 2016 Mar;56(1):37-40.

PMID:
27180506
12.

Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine.

Chamcha V, Kannanganat S, Gangadhara S, Nabi R, Kozlowski PA, Montefiori DC, LaBranche CC, Wrammert J, Keele BF, Balachandran H, Sahu S, Lifton M, Santra S, Basu R, Moss B, Robinson HL, Amara RR.

Open Forum Infect Dis. 2016 Feb 11;3(1):ofw034. doi: 10.1093/ofid/ofw034. eCollection 2016 Jan.

13.

Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus Macaques.

Iyer SS, Gangadhara S, Victor B, Gomez R, Basu R, Hong JJ, Labranche C, Montefiori DC, Villinger F, Moss B, Amara RR.

J Immunol. 2015 Aug 1;195(3):994-1005. doi: 10.4049/jimmunol.1500083. Epub 2015 Jun 26.

14.

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection.

Kwa S, Sadagopal S, Shen X, Hong JJ, Gangadhara S, Basu R, Victor B, Iyer SS, LaBranche CC, Montefiori DC, Tomaras GD, Villinger F, Moss B, Kozlowski PA, Amara RR.

J Virol. 2015 Apr;89(8):4690-5. doi: 10.1128/JVI.03527-14. Epub 2015 Feb 4.

15.

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.

Kwa S, Lai L, Gangadhara S, Siddiqui M, Pillai VB, Labranche C, Yu T, Moss B, Montefiori DC, Robinson HL, Kozlowski PA, Amara RR.

J Virol. 2014 Sep 1;88(17):9579-89. doi: 10.1128/JVI.00975-14. Epub 2014 Jun 11.

16.

Local control of repeated-dose rectal challenges in DNA/MVA-vaccinated macaques protected against a first series of simian immunodeficiency virus challenges.

Kannanganant S, Gangadhara S, Lai L, Lawson B, Kozlowski PA, Robinson HL, Amara RR.

J Virol. 2014 May;88(10):5864-9. doi: 10.1128/JVI.00145-14. Epub 2014 Feb 26.

17.

Pro-metastatic tumor-stroma interactions in breast cancer.

Gangadhara S, Barrett-Lee P, Nicholson RI, Hiscox S.

Future Oncol. 2012 Nov;8(11):1427-42. doi: 10.2217/fon.12.134. Review.

PMID:
23148616
18.

Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.

Garber DA, O'Mara LA, Gangadhara S, McQuoid M, Zhang X, Zheng R, Gill K, Verma M, Yu T, Johnson B, Li B, Derdeyn CA, Ibegbu C, Altman JD, Hunter E, Feinberg MB.

J Virol. 2012 Dec;86(23):12605-15. doi: 10.1128/JVI.00246-12. Epub 2012 Sep 12.

19.

Pediatric Orbital Blow-Out Fractures: Surgical Outcomes.

Ng JY, Gangadhara S, Wanling W, Amrith S.

Asia Pac J Ophthalmol (Phila). 2012 Sep-Oct;1(5):265-9. doi: 10.1097/APO.0b013e31825f8976.

20.

Rhinosporidiosis - a report of two cases.

Rajeshwari A, Gangadhara S, Deviprasad S, Manohar S.

Indian J Otolaryngol Head Neck Surg. 2010 Sep;62(3):322-5. doi: 10.1007/s12070-010-0082-9. Epub 2010 Oct 12.

21.

Exemestane in postmenopausal women with early or advanced breast cancer: a review.

Bertelli G, Gangadhara S.

Expert Opin Pharmacother. 2010 Aug;11(11):1933-42. doi: 10.1517/14656566.2010.495945. Review.

PMID:
20569090
22.

Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women.

Gangadhara S, Bertelli G.

Ther Clin Risk Manag. 2009 Aug;5(4):291-300. Epub 2009 May 4.

23.

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.

Garber DA, O'Mara LA, Zhao J, Gangadhara S, An I, Feinberg MB.

PLoS One. 2009;4(5):e5445. doi: 10.1371/journal.pone.0005445. Epub 2009 May 6.

24.

Small-cell neuroendocrine carcinoma originating from the lateral nasopharyngeal wall.

Deviprasad S, Rajeshwari A, Tahir M, Adarsha TV, Gangadhara S.

Ear Nose Throat J. 2008 Nov;87(11):E1-3.

PMID:
19006052
25.

High throughput spectrometer for fast localized Doppler measurements.

Craig D, Den Hartog DJ, Ennis DA, Gangadhara S, Holly D.

Rev Sci Instrum. 2007 Jan;78(1):013103.

PMID:
17503903
26.

Spatially resolved measurements of ion heating during impulsive reconnection in the Madison Symmetric Torus.

Gangadhara S, Craig D, Ennis DA, Hartog DJ, Fiksel G, Prager SC.

Phys Rev Lett. 2007 Feb 16;98(7):075001. Epub 2007 Feb 12.

PMID:
17359029
27.

Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles.

Skountzou I, Quan FS, Gangadhara S, Ye L, Vzorov A, Selvaraj P, Jacob J, Compans RW, Kang SM.

J Virol. 2007 Feb;81(3):1083-94. Epub 2006 Nov 15.

Supplemental Content

Loading ...
Support Center